Publication|Videos|April 19, 2024
Interview with Hayley Crowe, Executive VP & GM at Ecolab Global Life Sciences
Hayley Crowe, Executive VP & GM at Ecolab Global Life Sciences, talks about the company's services and how they relate to trends in bioprocessing and purification.
Key Learning Objectives:
- Learn more about Ecolab’s new Life Sciences Sector and Ecolab’s investment into additional supply capacity globally.
- Learn more about Purolite’s bioprocessing division and unique technologies.
- Understand how Purolite is addressing key challenges and trends in bioprocessing purification.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
![[Rishi Pimentel, gChem]](https://cdn.sanity.io/images/0vv8moc6/pharmtech/16bc98940a34f0991f9ca5e7ccbfa6889fec078f-1634x909.jpg?w=350&fit=crop&auto=format)
![[Rishi Pimentel, gChem]](https://cdn.sanity.io/images/0vv8moc6/pharmtech/01d391920288b8bd8b751988988b5a6544a6ddaa-1629x908.jpg?w=350&fit=crop&auto=format)
![[Nigel Langley]](https://cdn.sanity.io/images/0vv8moc6/pharmtech/e2c0137d8224aaa1f14c0f1af43b58d21f4541dd-1768x904.jpg?w=350&fit=crop&auto=format)
Trending on Pharmaceutical Technology
1
Batch Certification for New Manufacturing Technologies: The Qualified Person Role in a Digital Environment
2
Why Pharma’s AI Agents Need Smaller, Domain-Specific Models First
3
BirchBioMed’s Idiopathic Pulmonary Fibrosis Treatment Receives Orphan Drug Designation
4
FDA Deploys Agentic AI Capabilities for Agency Staff
5
